Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,430 | -43,701 | -19,620 | -55,350 | -40,462 |
| Depreciation Amortization | 490 | 356 | 231 | 572 | 368 |
| Accounts receivable | -7,626 | 5,000 | 5,000 | -5,000 | N/A |
| Accounts payable and accrued liabilities | -29 | 735 | 836 | -600 | 378 |
| Other Working Capital | 85,590 | 7,824 | 4,946 | -4,481 | -3,611 |
| Other Operating Activity | 17,136 | 6,280 | -3,091 | 13,424 | 4,768 |
| Operating Cash Flow | $42,131 | $-23,506 | $-11,698 | $-51,435 | $-38,559 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 154 | 154 |
| PPE Investments | -575 | -289 | -135 | 75 | 84 |
| Investing Cash Flow | $-575 | $-289 | $-135 | $229 | $238 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,838 | N/A | N/A | N/A | N/A |
| Debt Repayment | -19,313 | -4,200 | -2,100 | -2,800 | -700 |
| Common Stock Issued | 12,691 | 2,401 | 117 | 32,126 | 31,464 |
| Other Financing Activity | -3,595 | -4,528 | -3,387 | 75,715 | 5,743 |
| Financing Cash Flow | $14,621 | $-6,327 | $-5,370 | $105,041 | $36,507 |
| Exchange Rate Effect | -88 | -42 | -84 | 34 | 24 |
| Beginning Cash Position | 91,551 | 91,551 | 91,551 | 37,682 | 37,682 |
| End Cash Position | 147,640 | 61,387 | 74,264 | 91,551 | 35,892 |
| Net Cash Flow | $56,089 | $-30,164 | $-17,287 | $53,869 | $-1,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,131 | -23,506 | -11,698 | -51,435 | -38,559 |
| Capital Expenditure | -625 | -334 | -135 | -47 | -10 |
| Free Cash Flow | 41,506 | -23,840 | -11,833 | -51,482 | -38,569 |